Publicador de contenidos

Investigación

OBERON

An integrative strategy of testing systems for identification of EDs related to metabolic disorders

Proyecto OBERON
Duración
01/01/2019 - 31/12/2023
Coordinador
Karine Audouze
Financiadores
European Union’s Horizon 2020

Exposure to chemical substances that can produce endocrine disrupting effects represents one of the most critical public health threats nowadays. In line with the regulatory framework implemented within the European Union to reduce the levels of endocrine disruptors (EDs) for consumers, new and effective methods for ED testing are needed.

The OBERON project will build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems.

Total funding

€ 5,978,762

Nuestro equipo

Coordinator

  • Karine Audouze
    Karine Audouze

ISGlobal Team

Otros proyectos

ENDOMIX

Understanding how endocrine disruptors and chemical mixtures of concern target the immune system to trigger or perpetuate disease

AM-MENTAL

¿Cómo afecta a tu salud mental que tu jefe o jefa sea un algoritmo?

PANAMA

Inhaled dose of air pollution - an integrative approach towards personalized air pollution exposure assessment in participants with and without respiratory diseases

e-QuoL

e-health tools to promote Equality in Quality of Life for childhood to young adulthood cancer patients, survivors and their families

B-Triage

Una prueba en el punto de atención para la estratificación del riesgo de los pacientes febriles basada en los niveles de sTREM-1

IHEN

International Human Exposome Network

EXPONIT

Analysing and studying how night shift work affects workers' circadian rhythms and health